Table 1.
Demographic and clinical characteristics of the study participants (n = 500).
| Mean (SD) or % | |
|---|---|
| Age (y) | 73.3 (7.5) |
| Female sex | 55 |
| Education (years) | 7.84 (4.8) |
| Amnestic MCI profile | 82.6 |
| Probable MCI status | 41.8 |
| MMSE score | 25.45 (3.3) |
| APOE ε4 carrier | 36.4 |
| AT(N) profiles | |
| Normal | 26.8 |
| SNAP | 17.6 |
| Brain amyloidosis | 14.4 |
| Prodromal AD | 41.6 |
| NPS | |
| Depression/Dysphoria | 50.4 |
| Anxiety | 43.6 |
| Apathy/Indifference | 37.6 |
| Irritability/Lability | 35.4 |
| Nighttime Behaviors | 20.6 |
| Time of follow-up (years) | 2.08 (1.2) |
AD: Alzheimer’s disease MCI: mild cognitive impairment; MMSE: Mini-Mental State Examination; NPSs: Neuropsychiatric Symptoms; SNAP: Suspected Non-Alzheimer’s Pathology.